21224 ⎘
Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen Polysaccharides; Lipopolysaccharides [LPS]
COMPOSITIONS AND METHODS CONCERNING IMMUNE TOLERANCE
#2GLYCOTARGETING THERAPEUTICS
#3Vaccines and Antibodies for the Treatment and Prevention of Neurodegenerative Disorders and Inflammation Related Health Conditions
#4NOVEL COMPOSITIONS COMPRISING TERPENOID AND MACROMOLECULE, AND USES THEREOF
#5ORAL VACCINE FOR ENHANCING CANCER IMMUNOTHERAPY
#6TETRASACCHARIDES FOR THE DIAGNOSIS, PREVENTION, AND TREATMENT OF MELIOIDOSIS AND GLANDERS
#7LIPID NANOCARRIER VACCINE
#8METHODS FOR TREATING CANCER WITH ACTIVATING ANTIGEN CARRIERS
#9PEGYLATED LIPOSOMES AND METHODS OF USE
#10IMMUNE ENHANCEMENT AND INFECTIOUS DISEASE TREATMENT
#11COMBINED VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS
#12A CONJUGATE COMPRISING AT LEAST A ß-GLUCAN
#13PROTEIN ANTIGENS THAT PROVIDE PROTECTION AGAINST PNEUMOCOCCAL COLONIZATION AND/OR DISEASE
#14CHEMICALLY MODIFIED BACTERIAL PEPTIDOGLYCAN COMPOSITIONS AND USES THEREOF
#15OLIGOSACCHARIDE COMPLEXES AND USES
#16PNEUMOCOCCAL POLYPEPTIDE ANTIGENS
#17Glyconjugate Vaccines
#18MOLECULAR VACCINES FOR INFECTIOUS DISEASE
#19STABILIZATION OF ADJUVANTED VACCINE COMPOSITIONS AND THEIR USE
#20COMPOSITION FOR IMMUNE TREATMENT OF ALLERGIC DISEASES COMPRISING HOUSE DUST MITE ANTIGENS AND HYALURONIC ACID HYDROGELS AS ACTIVE INGREDIENTS
#21TARGETED GLYCOSAMINOGLYCAN-PARTICLES AND METHODS OF USE
#22SUBUNIT VACCINES WITH DINUCLEOTIDE-LOADED HYDROGEL ADJUVANT
#23MULTIPLE FUNCTIONALIZED noMV CONJUGATES
#24BIOCONJUGATES MADE FROM RECOMBINANT N-GLYCOSYLATED PROTEINS FROM PROCARYOTIC CELLS
#25COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE
#26INACTIVATED VACCINES & NUCLEIC ACID APTAMER THERAPEUTICS DERIVED THEREFROM
#27VACCINE
#28OLIGOSACCHARIDE VACCINE FOR SPECIFIC PREVENTION OF FUNGAL INFECTIONS AND METHOD FOR PREPARING SAME
#29GLYCAN MODIFIED SPIKE RECEPTOR BINDING DOMAIN NANOPARTICLES AND METHOD OF USE THEREOF AS A CORONAVIRUS DISEASE 2019 (COVID-19) VACCINE
#30VACCINE
#31COMPOSITIONS AND METHODS FOR PRODUCING GLYCO-MODIFIED VIRAL ANTIGENS
#32Antigens for detecting toxoplasma infection by monitoring cellular immunity
#33PROTECTED DISACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF ZWITTERIONIC OLIGOSACCHARIDES, AND CONJUGATES THEREOF
#34PURIFICATION PROCESSES FOR POLYSACCHARIDES AND POLYPEPTIDE CONJUGATES THEREOF
#35Polysaccharide and uses thereof
#36METHOD FOR IMPROVING IMMUNOGENICITY OF PROTEIN/PEPTIDE ANTIGEN
#37Antigen presenting scaffolds for immune-cell manipulation
#38GROUP A STREP IMMUNOGENIC COMPOSITIONS WITH POLYSACCHARIDE-PROTEIN CONJUGATES
#39Glyconjugate vaccines
#40CORONAVIRUS VACCINE
#41ANTI-INFECTION AND ANTI-TUMOR MUCOSAL IMMUNE PREPARATION
#42Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates
#43DETOXIFIED LIPOPOLYSACCHARIDES (LPS), NATURALLY NON-TOXIC LPS, AND USES THEREOF
#44GLYCOTARGETING THERAPEUTICS
#45Protein antigens that provide protection against pneumococcal colonization and/or disease
#46Methods and compositions for immune protection against extra-intestinal pathogenic
#47IMMUNOGENIC COMPOSITION
#48Composite-type nano-vaccine particle
#49NOVEL IMMUNOGENS AND METHODS FOR DISCOVERY AND SCREENING THEREOF
#50Production of 018 bioconjugates
#51MODIFIED VIRUS-LIKE PARTICLES OF CMV
#52METHODS FOR TREATING CANCER WITH ACTIVATING ANTIGEN CARRIERS
#53ANTIMICROBIAL VACCINE COMPOSITIONS
#54ANTIGENS FOR DETECTING TOXOPLASMA INFECTION BY MONITORING CELLULAR IMMUNITY
#55Vaccine Adjuvants for Antigen Delivery
#56NANOPARTICLES FOR USE IN REDIRECTION AGAINST THE TUMOUR OF A NON-TUMOUR SPECIFIC IMMUNE RESPONSE, BASED ON A PRE-EXISTING IMMUNITY
#57TETRASACCHARIDES FOR THE DIAGNOSIS, PREVENTION, AND TREATMENT OF MELIOIDOSIS AND GLANDERS
#58COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE
#59Therapeutics for autoimmune disease: synthetic antigens
#60Immunomodulatory lipopolysaccharide compositions
#61CANCER VACCINE FORMULATION
#62Pegylated liposomes and methods of use
#63Immunogenic compositions
#64Multi-functionalized nOMV conjugates
#65METHODS OF USE & COMPOSITIONS OF IBD, IBS, & ANTINEOPLASTIC MICROBIAL THERAPEUTICS
#66ExPEC glycoconjugate vaccine formulations
#67COMPOSITIONS AND METHODS CONCERNING IMMUNE TOLERANCE
#68Acinetobacter O-oligosaccharyltransferases and uses thereof
#69Polysaccharide and uses thereof
#70Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells
#71Methods and compositions for immune protection against extra-intestinal pathogenic
#72Mucosal adjuvants and delivery systems
#73Immunogenic compositions
#74PSEUDOMONAS ANTIGENS AND ANTIGEN COMBINATIONS
#75COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE
#76Modified virus-like particles of CMV
#77Immunogenic compositions for the prevention and treatment of meningococcal disease
#78PEGylated liposomes and methods of use
#79Glycotargeting therapeutics
#80Polysaccharide and uses thereof
#81Combined vaccine against mycobacterium tuberculosis
#82Tumor vaccine and uses thereof
#83Antigenic combinations against bacteria and related nanolipoprotein particles, compositions, methods and systems
#84ExPEC glycoconjugate vaccine formulations
#85Compositions and methods for inducing immune tolerance
#86Nanoscale artificial antigen presenting cells
#87Bordetella vaccines comprising LPS with reduced reactogenicity
#88Acinetobacter o-oligosaccharyltransferases and uses thereof
#89Antigen presenting scaffolds for immune-cell manipulation
#90Molecular vaccines for infectious disease
#91Immune modulator and vaccine composition containing the same
#92Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates
#93Antigens for detecting toxoplasma infection by monitoring cellular immunity
#94Vaccine
#95Compositions and Methods for Increasing Immunogenicity of Glycoprotein Vaccines
#96Mucosal adjuvants and delivery systems
#97Methods to Treat Diseases with Protein, Peptide and Antigen Modification
#98ExPEC glycoconjugate vaccine formulations
#99PcrV-linked antigen vaccines
#100Long chain antigen containing interepitope sequence that promotes antigen presentation to T cells
#101Bordetella pertussis immunogenic vaccine compositions
#102Immunogenic construct comprising an EBV-cell antigen and a targeting moiety and applications thereof
#103Anti-infection and anti-tumor mucosal immune preparation
#104Glycotargeting therapeutics
#105Vaccine
#106Polymer conjugate vaccines
#107PSEUDOMONAS ANTIGENS AND ANTIGEN COMBINATIONS
#108VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES
#109Methods and compositions for immune protection against extra-intestinal pathogenic
#110fusion protein and construction method and use thereof
#111Pneumococcal capsular saccharide conjugate vaccine
#112Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
#113Polysaccharide vaccine formulations and processes for industrial production of bacterial polysaccharides
#114ExPEC glycoconjugate vaccine formulations
#115Compositions and methods for producing bacterial conjugate vaccines
#116Antigen specific Tregs and related compositions, methods and systems
#117Acinetobacter O-oligosaccharyltransferases and uses thereof
#118Polysaccharide and uses thereof
#119Modified virus-like particles of CMV
#120Compositions and methods for increasing immunogenicity of glycoprotein vaccines
#121Immunogenic compositions for the prevention and treatment of meningococcal disease
#122Mucosal adjuvants and delivery systems
#123Antigen-loaded chitosan nanoparticles for immunotherapy
#124Capsular gram-positive bacteria bioconjugate vaccines
#125CYTOKINE-CHITOSAN BIOCONJUGATES AND METHODS OF USING THE SAME
#126Combinatorial platform for the display of surface adjuvants and antigens
#127Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
#128Biodegradable nanocomplex
#129Peptide/β-1,3-glucan complex and production method thereof and pharmaceutical composition containing peptide/β-1,3-glucan complex
#130Meningococcal conjugate vaccine for groups A, C, Y and W135 and a preparation method thereof
#131Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
#132immunogenic vaccine compositions
#133Protein and peptide-free synthetic vaccines against type 3
#134Vaccine comprising capsular polysaccharide conjugates
#135Polysaccharide-protein conjugate vaccines
#136LOS-derived oligosaccharide with pertussis toxin glycoconjugate and its application in the prophylaxis and treatment of infections caused by
#137Vaccine formulation for ocular immunization
#138Nanoscale artificial antigen presenting cells
#139Immunogenic composition
#140Protein antigens that provide protection against pneumococcal colonization and/or disease
#141Immunologically active compositions
#142Immunogenic compositions for the prevention and treatment of meningococcal disease
#143antigens and antigen combinations
#144Pneumoccal polysacchride conjugate vaccine
#145Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
#146Pharmaceutical composition comprising a solid nanoparticle and at least an antigen for the treatment against an intracellular pathogenic agent
#147Carbohydrate-glycolipid conjugate vaccines
#148Polysaccharide and uses thereof
#149Immunogenic compositions for the prevention and treatment of meningococcal disease
#150Shortened purification process for the production of capsular polysaccharides
#151Composition comprising a colloidal synthetic bioresorbable vector and a viral vector
#152Bacterial biofilm matrix as a platform for protein delivery
#153Method for manufacturing transdermally delivered hyaluronic acid-protein conjugate and transdermally delivered hyaluronic acid-protein conjugate manufactured using same
#154Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells
#155Capsular gram-positive bacteria bioconjugate vaccines
#156Mucosal vaccine using cationic nanogel
#157Drug delivery product and methods
#158Activation of polysaccharides via the cyanylating agent, 1-cyanobenzotriazole (1-CBT), in the preparation of polysaccharide/protein conjugate vaccines
#159VACCINE PREPARATION FOR CANCER TREATMENT
#160Activation of polysaccharides via the cyanylating agent, 2-cyanopyridazine-3(2H)-one (2-CPO), in the preparation of polysaccharide/protein conjugate vaccines
#161Activation of polysaccharides via the cyanylating agent, 1-cyanoimidazole (1-Cl), in the preparation of polysaccharide/protein conjugate vaccines
#162Immunologically modified carbon nanotubes for cancer treatment
#163Compositions for transfection of biomolecules into cells
#164ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISMS INCLUDING LACTIC ACID BACTERIAL STRAINS
#165COMPOSITIONS AND METHODS FOR TREATING AIRWAY INFLAMMATORY DISEASES
#166Novel Immunogenic Compositions For The Prevention And Treatment of Meningococcal Disease
#167Immunogenic compositions for the prevention and treatment of meningococcal disease
#168Immunogenic compositions for the prevention and treatment of meningococcal disease
#169Activation of polysaccharides via the cyanylating agent, 1-cyano-4-pyrrolidinopyridinium tetrafluoroborate (CPPT), in the preparation of polysaccharide/protein conjugate vaccines
#170Molecular vaccines for infectious disease
#171Immunologically modified carbon nanotubes for cancer treatment
#172Immunogenic compositions for the prevention and treatment of meningococcal disease
#173METHODS OF IMPROVING VACCINE IMMUNOGENICITY
#174Pharmaceutical composition of an antigenic tau peptide reconstituted in a liposome and related antibodies and cell lines
#175ANALYSIS OF SACCHARIDE VACCINES WITHOUT INTERFERENCE
#176Oral vaccine fast-dissolving dosage form using starch
#177Non-aqueous synthesis of polysaccharide-protein conjugates for vaccines
#178Polysaccharide-protein conjugate vaccines
#179Nanoparticles for Extravascular Administration
#180NOVEL IMMUNOGENIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MENINGOCOCCAL DISEASE
#181Antigen Specific Tregs and related compositions, methods and systems
#182Capsular gram-positive bacteria bioconjugate vaccines
#183Conjugates comprising mannan and myelin oligodentrocyte glycoprotein (MOG)
#184MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
#185MUCOSAL VACCINE USING CATIONIC NANOGEL
#186Synergistic immunogenic fusion protein-polysaccharide conjugate
#187Identification of a conserved inner core oligosaccharide of lipopolysaccharide as a vaccine antigen
#188Immunologically active compositions
#189Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells
#190Immunogenic compositions for the prevention and treatment of meningococcal disease
#191PEPTIDE CONJUGATE COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE
#192SUGAR IMMUNOGENS
#193VACCINE
#194PHARMACEUTICAL FORMULATION FOR ALLERGEN PREPARATION
#195COMBINATION VACCINES WITH 1-HYDROXY-2-PHENOXYETHANE PRESERVATIVE
#196Drug delivery product and methods
#197Stable vaccine compositions and methods of use
#198COMPOSITIONS AND METHODS FOR CHITOSAN ENHANCED IMMUNE RESPONSE
#199Compositions and methods for increasing immunogenicity of glycoprotein vaccines
#200protein antigens and methods
#201protein antigens and methods
#202VACCINE COMPOSITIONS AND METHODS OF USE
#203POLYVALENT BIOCONJUGATES
#204Pneumococcal polysaccharide conjugate vaccine
#205Fusion protein vaccine
#206Amyloid-beta polypeptide vaccine
#207Flu vaccine admixture of mannan and flu antigen
#208NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#209TARGETED AND HIGH DENSITY DRUG LOADED POLYMERIC MATERIALS
#210METHODS OF TREATMENT WITH DRUG LOADED POLYMERIC MATERIALS
#211Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease
#212Method for the preparation of specific antibodies against saccharidic antigens
#213Liposome-mediated ligation
#214Composition Comprising a Colloidal Synthetic Bioresorbable Vector and a Viral Vector
#215Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease
#216NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#217Glycolipopeptide antibodies
#218Vaccine
#219Vaccine Comprising Streptococcus Pneumoniae Capsular Polysaccharide Conjugates
#220Pneumococcal Polysaccharide Conjugate Vaccine
#221Separation of Unconjugated and Conjugated Saccharide by Solid Phase Extraction
#222Shortened purification process for the production of capsular polysaccharides
#223Analysis of saccharide vaccines without interference
#224Preparation of Salmonella Broad-Spectrum Vaccines
#225Compositions and methods for treating or preventing pneumococcal infection
#226Sugar immunogens
#227Cancer Vaccine Preparation
#228Abasic Oligonucleotide as Carrier Platform for Antigen and Immunostimulatory Agonist and Antagonist
#229Chitin Micro-Particles As An Adjuvant
#230Methods of treatment with drug loaded polymeric materials
#231Purification Process for Bacterial Cytolysin
#232HIV-1 glycopeptides and derivatives; preparation and applications thereof
#233Polysaccharide-protein conjugate vaccines
#234Method for modulating the binding activity of a novel ICAM-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes
#235Compositions for immunotherapy and uses thereof
#236Compositions for immunotherapy and uses thereof
#237NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#238Immunogenic compositions for the prevention and treatment of meningococcal disease
#239Composition and method for preventing or treating a virus infection
#240Streptococcal C5A peptidase vaccine
#241Conjugated hydroxyalkyl starch allergen compounds
#242Methods of treatment with drug loaded polymeric materials
#243Targeted and high density drug loaded polymeric materials
#244Drug delivery product and methods
#245Carbohydrate-based synthetic vaccines for HIV
#246Novel method for down-regulation of amyloid
#247Streptococcal C5a peptidase vaccine
#248Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens
#249Polysaccharide vaccine for staphylococcal infections
#250Microparticles comprising carbohydrate beads covalently linked with allergen
#251Oral vaccine for peste-des-petits-ruminants virus